Table 2.
Cases with recurrence of endometrioid-type endometrial carcinoma at intermediate risk, according to some patient characteristics, management, and recurrence pattern.
| Case (Age) | First treatment |
Recurrence |
Survival post-relapse§ (months) | ||||
|---|---|---|---|---|---|---|---|
| Year | Lymph-adenectomy | Stage* | Adjuvant radiotherapy | Site | Time after treatment (months) | ||
| 1 (75y) | 1996 | No | IBG2 | EBRT | Pelvic | 50 | 4 |
| 2 (73y) | 2014 | No | IAG3 | EBRT | Upper abdomen | 24 | 1 |
| 3 (61y) | 1990 | Yes | IAG2 | VBT | Upper abdomen | 31 | 18 |
| 4 (57y) | 1991 | Yes | IAG2 | EBRT | Neck limph node | 59 | 9 |
| 5 (57y) | 1992 | Yes | IBG2 | EBRT | Lung | 6 | 23 |
| 6 (64y) | 1993 | Yes | IAG2 | EBRT | Pelvic | 26 | 10 |
| 7 (67y) | 1993 | Yes | IAG3 | VBT | CNS | 5 | 1 |
| 8 (68y) | 1993 | Yes | IAG3 | EBRT | Pelvic | 48 | 2 |
| 9 (61y) | 1995 | Yes | IBG1 | EBRT | Upper abdomen | 20 | 5 |
| 10 (70y) | 1996 | Yes | IAG3 | EBRT | Lung | 6 | 3 |
| 11 (47y) | 2004 | Yes | IBG2 | EBRT | Para-aortic | 64 | 34 |
| 12 (65y) | 2008 | Yes | IAG3 | EBRT | CNS | 20 | 7 |
| 13 (62y) | 2009 | Yes | IAG2 | VBT | Vagina | 11 | 7 |
| 14 (64y) | 2010 | Yes | IAG2 | VBT | Para-aortic | 185 | 24 |
EBRT: external beam radiotherapy; VBT: vaginal brachytherapy; CNS: central nervous system; NA: not available.
*
FIGO Stage/2014 [16]: A=myometrial invasion <50% deep; B=≥50% deep; G=histological grade.
§
Survival post-relapse: time after recurrence and until death.